Covidien touts EU win for EverFlex stent

January 23, 2013 by MassDevice staff

Medical device maker Covidien wins CE Mark approval in the European Union for its EverFlex self-expanding stent system.

Covidien logo

Medical device company Covidien (NYSE:COV) announced CE Mark approval in the European Union for its EverFlex self-expanding peripheral stent as well as for the accompanying Entrust delivery system.

Covidien plans to roll out the device in Western Europe next month, according to a press release.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp